pravastatin has been researched along with Adenocarcinoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornejo-Uixeda, S; Escoin-Pérez, C; Hernandez-Lorente, E | 1 |
| Chen, Y; Li, LB; Tang, DP; Wei, JJ; Zhang, J; Zhuang, ZH | 1 |
| Albertsson, M; Holmqvist, A; Kotti, A; Sun, XF | 1 |
| de Jongh, FE; Eskens, FA; Konings, IR; Sleijfer, S; van der Gaast, A; van der Wijk, LJ | 1 |
| Fullerton, DA; Meng, X; Reece, TB; Reppert, AE; Sadaria, MR; Weyant, MJ; Yu, JA | 1 |
| Bonnet, E; Breton, Y; Forestier, F; Janvier, G | 1 |
| Beales, IL; Ogunwobi, OO | 1 |
| Hawk, ET; Viner, JL | 1 |
| Fukaura, Y; Ishikawa, C; Narisawa, T; Tanida, N; Terada, K; Umezawa, A; Yazawa, K | 1 |
| Baba, M; Iishi, H; Nakaizumi, A; Sakai, N; Tatsuta, M; Uehara, H; Yano, H | 1 |
1 trial(s) available for pravastatin and Adenocarcinoma
| Article | Year |
|---|---|
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pravastatin; Stomach Neoplasms | 2010 |
9 other study(ies) available for pravastatin and Adenocarcinoma
| Article | Year |
|---|---|
Capecitabine-induced pancreatitits.
Topics: Abdomen, Acute; Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Oxaliplatin; Pancreatitis; Pravastatin; Sigmoid Neoplasms | 2018 |
Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation; Humans; Pravastatin; Simvastatin | 2018 |
Survival benefit of statins in older patients with rectal cancer: A Swedish population-based cohort study.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Cohort Studies; Disease-Free Survival; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Pravastatin; Proportional Hazards Models; Protective Factors; Rectal Neoplasms; Retrospective Studies; Simvastatin; Survival Rate; Sweden | 2019 |
Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Atorvastatin; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Esophageal Neoplasms; Flow Cytometry; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; NF-kappa B; Pravastatin; Pyrroles; Simvastatin | 2011 |
Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins.
Topics: Adenocarcinoma; Creatine Kinase; Creatinine; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Laparoscopy; Male; Middle Aged; Paralysis; Postoperative Complications; Pravastatin; Rectal Neoplasms; Rectum; Rhabdomyolysis | 2002 |
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Apoptosis; Barrett Esophagus; Caspase 3; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Mevalonic Acid; Nitrobenzenes; Polyisoprenyl Phosphates; Pravastatin; Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Simvastatin; Sulfonamides | 2008 |
Statins in esophageal cancer cell lines: promising lead?
Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin | 2008 |
Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Anticarcinogenic Agents; Carcinogens; Cholesterol; Colonic Neoplasms; Dimethylhydrazines; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Mice, Inbred ICR; Pravastatin; Simvastatin | 1994 |
ras p21 Isoprenylation inhibition induces flat colon tumors in Wistar rats.
Topics: Adenocarcinoma; Adenoma; Analysis of Variance; Animals; Antimetabolites; Apoptosis; Azoxymethane; Blotting, Western; Bromodeoxyuridine; Carcinogens; Colonic Neoplasms; Colonic Polyps; Genes, ras; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Oncogene Protein p21(ras); Point Mutation; Pravastatin; Prevalence; Protein Prenylation; Random Allocation; Rats; Rats, Wistar | 2000 |